These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 208798)

  • 1. [Inhibitory effects of LHRH on LH receptors in the rat testis].
    Auclair C; Ferland L; Cusan L; Kelly PA; Labrie F; Azadian-Boulanger G; Raynaud JP
    C R Acad Hebd Seances Acad Sci D; 1978 May; 286(18):1305-7. PubMed ID: 208798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of testicular androgen biosynthesis and LH receptor levels by an LHRH agonist: role of prolactin.
    Belanger A; Auclair C; Seguin C; Kelly PA; Labrie F
    Mol Cell Endocrinol; 1979 Jan; 13(1):47-53. PubMed ID: 221286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibitory activity of [D-Leu6, Des-Gly-NH2(10)]LHRH ethylamide on LH/hCG and PRL testicular receptor levels in the rat.
    Auclair C; Kelly PA; Coy DH; Schally AV; Labrie F
    Endocrinology; 1977 Dec; 101(6):1890-3. PubMed ID: 201452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of long term treatment with a luteinizing hormone-releasing hormone agonist on the pituitary-gonadal axis in male and female rats.
    Cusan L; Auclair C; Belanger A; Ferland L; Kelly PA; Seguin C; Labrie F
    Endocrinology; 1979 May; 104(5):1369-76. PubMed ID: 220032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medrogestone and an LHRH analogue as potential combination therapy for hormone-dependent cancers.
    Auclair C; Givner ML
    Arch Androl; 1982 Feb; 8(1):21-4. PubMed ID: 7039538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary-testis function in rats treated neonatally with a gonadotrophin-releasing hormone agonist: short- and long-term effects.
    Garnelo P; Pinilla L; Gaytan F; Aguilar E
    J Endocrinol; 1992 Aug; 134(2):269-77. PubMed ID: 1402537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of the chronic administration of a potent luteinizing hormone releasing hormone analog on the rat prostate.
    Trachtenberg J
    J Urol; 1982 Nov; 128(5):1097-100. PubMed ID: 6294350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the direct action of luteinizing hormone-releasing hormone agonists at the testicular level in intact rats treated with an antiluteinizing hormone serum.
    Séguin C; Bélanger A; Labrie F; Hansel W
    Endocrinology; 1982 Feb; 110(2):524-30. PubMed ID: 6276140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an LHRH agonist on endocrine function, LHRH receptor and LH/hCG receptor in the pituitary-gonadal axis of male rats.
    Komatsu M; Iwahana H; Mitsuhashi S
    Endocrinol Jpn; 1986 Apr; 33(2):185-95. PubMed ID: 3019649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent tissues in the rat.
    Séguin C; Cusan L; Bélanger A; Kelly PA; Labrie F; Raynaud JP
    Mol Cell Endocrinol; 1981 Jan; 21(1):37-41. PubMed ID: 6259002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of flutamide action on prostatic and testicular functions in the rat.
    Marchetti B; Labrie F
    J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oestrogen and GnRH agonist analogue-induced inhibition of the pituitary-testicular function in rat.
    Huhtaniemi IT; Warren DD; Catt KJ
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):163-71. PubMed ID: 6305079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of pituitary-gonadal function in male and female rats after prolonged administration of a potent antagonist of luteinizing hormone-releasing hormone (SB-75).
    Bokser L; Srkalovic G; Szepeshazi K; Schally AV
    Neuroendocrinology; 1991 Aug; 54(2):136-45. PubMed ID: 1662786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LHRH and analogues as potential therapy for benign prostatic hyperplasia and hormone-dependent cancers.
    Auclair C; Stern M; Givner ML
    Arch Androl; 1981 Nov; 7(3):237-44. PubMed ID: 6171216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined long-term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat.
    Lefebvre FA; Séguin C; Bélanger A; Caron S; Sairam MR; Raynaud JP; Labrie F
    Prostate; 1982; 3(6):569-78. PubMed ID: 6296803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proopiomelanocortin-derived peptides in testicular interstitial fluid: characterization and changes in secretion after human chorionic gonadotropin or luteinizing hormone-releasing hormone analog treatment.
    Valenca MM; Negro-Vilar A
    Endocrinology; 1986 Jan; 118(1):32-7. PubMed ID: 3000742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of pituitary and gonadal functions in alloxan-induced diabetic male rats.
    Cusan L; Bélanger A; Séguin C; Labrie F
    Mol Cell Endocrinol; 1980 Jun; 18(3):165-76. PubMed ID: 6248397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effects of LHRH on ovarian LH receptors in rats].
    Ferland L; Auclair C; Labrie F; Azadian-Boulanger G; Raynaud JP
    C R Acad Hebd Seances Acad Sci D; 1978 Apr; 286(14):1113-6. PubMed ID: 208794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and maintenance of gonadotropin and lactogen receptors in hypoprolactinemic rats.
    Huhtaniemi IT; Catt KJ
    Endocrinology; 1981 Aug; 109(2):483-90. PubMed ID: 6265191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
    Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
    Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.